X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (24) 24
pathology (17) 17
female (14) 14
cancer (12) 12
immunohistochemistry (9) 9
oncology (9) 9
abridged index medicus (8) 8
animals (7) 7
breast neoplasms - genetics (7) 7
middle aged (7) 7
adult (6) 6
male (6) 6
medicine, research & experimental (6) 6
mutation (6) 6
prognosis (6) 6
aged (5) 5
breast cancer (5) 5
cell line, tumor (5) 5
expression (5) 5
medical laboratory technology (5) 5
research (5) 5
adenocarcinoma - genetics (4) 4
antineoplastic agents - therapeutic use (4) 4
biochemistry & molecular biology (4) 4
biomarkers, tumor - genetics (4) 4
breast carcinoma (4) 4
breast neoplasms - drug therapy (4) 4
breast neoplasms - pathology (4) 4
carcinoma (4) 4
her2 (4) 4
in-situ hybridization (4) 4
lung neoplasms - genetics (4) 4
mice (4) 4
polymerase chain reaction (4) 4
receptor, erbb-2 - genetics (4) 4
sensitivity and specificity (4) 4
tumors (4) 4
acute myeloid-leukemia (3) 3
adenocarcinoma - pathology (3) 3
algorithms (3) 3
analysis (3) 3
apoptosis - drug effects (3) 3
article (3) 3
biomarkers (3) 3
biopsy (3) 3
biotechnology & applied microbiology (3) 3
breast neoplasms - diagnosis (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
chemotherapy (3) 3
classification (3) 3
comparative genomic hybridization (3) 3
egfr (3) 3
erbb-2 protein (3) 3
fluorescence (3) 3
gene expression (3) 3
gene expression profiling (3) 3
genetic aspects (3) 3
genetics & heredity (3) 3
guidelines (3) 3
health aspects (3) 3
hemic and lymphatic diseases (3) 3
heterozygosity (3) 3
high-throughput nucleotide sequencing (3) 3
in situ hybridization (3) 3
in situ hybridization, fluorescence (3) 3
in situ hybridization, fluorescence - methods (3) 3
leukemia, myeloid, acute - metabolism (3) 3
lung neoplasms - pathology (3) 3
molecular sequence data (3) 3
next-generation sequencing (3) 3
nuclear proteins - antagonists & inhibitors (3) 3
nuclear proteins - metabolism (3) 3
oncology, experimental (3) 3
pc12 cells (3) 3
rats (3) 3
receptor protein-tyrosine kinases - genetics (3) 3
reproducibility of results (3) 3
sequence analysis, dna (3) 3
transcription factors - antagonists & inhibitors (3) 3
trastuzumab (3) 3
treatment outcome (3) 3
adenocarcinoma - classification (2) 2
adenocarcinoma - diagnosis (2) 2
adjuvant trastuzumab (2) 2
amplification (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
apoptosis (2) 2
apoptosis - physiology (2) 2
base sequence (2) 2
biochemical research methods (2) 2
biological markers (2) 2
biomarkers, tumor - analysis (2) 2
breast neoplasms - classification (2) 2
breast-cancer (2) 2
cancer patients (2) 2
carcinoma - genetics (2) 2
carcinoma - pathology (2) 2
carcinoma, ductal, breast - genetics (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 04/2014, Volume 28, Issue 11, pp. 2155 - 2164
Journal Article
Journal Article
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 10/2016, Volume 890, pp. 25 - 36
The two clinically validated and Food and Drug Administration approved lung cancer predictive biomarkers (epidermal growth factor receptor mutations and... 
Crizotinib | Immunohistochemistry | RET | Reverse transcriptase polymerase chain reaction | Fluorescent in situ hybridization | BRAF | Multikinase inhibitors | HER2 | MET | ROS1 | ACQUIRED-RESISTANCE | RET FUSIONS | ROS1 FUSION PROTEINS | SOMATIC MUTATIONS | HARBORING BRAF MUTATIONS | ONCOLOGY | 1ST GLOBAL APPROVAL | RANDOMIZED PHASE-II | BIOLOGY | GENE COPY NUMBER | RECEPTOR TYROSINE KINASE | CLINICOPATHOLOGICAL FEATURES | Lung Neoplasms - drug therapy | Proto-Oncogene Proteins c-ret - metabolism | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Receptor, ErbB-2 - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Molecular Targeted Therapy | Protein-Tyrosine Kinases - genetics | Adenocarcinoma - metabolism | Anaplastic Lymphoma Kinase | Biomarkers, Tumor - metabolism | Adenocarcinoma - genetics | Proto-Oncogene Proteins B-raf - metabolism | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Adenocarcinoma - drug therapy | Drug Resistance, Neoplasm - genetics | Receptor Protein-Tyrosine Kinases - genetics | Proto-Oncogene Proteins B-raf - genetics | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Mutation | Proto-Oncogene Proteins c-ret - genetics
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 2014, Volume 13, Issue 5, pp. 1142 - 1154
The bromodomain and extra-terminal (BET) protein family members, including BRD4, bind to acetylated lysines on histones and regulate the expression of... 
SELECTIVE-INHIBITION | AML CELLS | ONCOLOGY | THERAPEUTIC TARGET | C-MYC | BROMODOMAIN INHIBITION | ACUTE MYELOID-LEUKEMIA | TRANSCRIPTIONAL REGULATION | HEMATOLOGIC MALIGNANCIES | CANCER | BET BROMODOMAINS | Apoptosis - drug effects | Humans | Leukemia, Myeloid, Acute - metabolism | Gene Expression Profiling | Genes, myc | Bcl-2-Like Protein 11 | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Membrane Proteins - metabolism | Hydroxamic Acids - pharmacology | Disease Models, Animal | Hematopoietic Stem Cells - drug effects | Panobinostat | Proto-Oncogene Proteins - metabolism | Promoter Regions, Genetic | Leukemia, Myeloid, Acute - pathology | RNA, Messenger - genetics | Gene Expression Regulation, Leukemic - drug effects | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Hematopoietic Stem Cells - metabolism | Neoplastic Stem Cells | Genes, bcl-2 | Apoptosis Regulatory Proteins - metabolism | Drug Synergism | Leukemia, Myeloid, Acute - mortality | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Animals | Oncogene Proteins, Fusion - genetics | Nuclear Proteins - antagonists & inhibitors | Cell Line, Tumor | Protein Binding | Histone Deacetylase Inhibitors - pharmacology | Mice | Cell Cycle - drug effects | Cluster Analysis | Leukemia, Myeloid, Acute - genetics
Journal Article
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 12, pp. 2230 - 2239
BACKGROUND The dual‐probe fluorescence in situ hybridization (FISH) assay for human epidermal growth factor receptor 2 (HER2) gene amplification in breast... 
pathology | human epidermal growth factor receptor 2 (HER2) | breast cancer | diagnosis | Erb‐B2 receptor tyrosine kinase 2 (ERBB2) | prognosis | in situ hybridization | Erb-B2 receptor tyrosine kinase 2 (ERBB2) | FISH TESTING INCREASE | HER-2/NEU STATUS | TRASTUZUMAB | POLYSOMY 17 | CENTROMERE | ONCOLOGY | RECOMMENDATIONS | COPY NUMBER | CARCINOMAS | SINGLE-INSTITUTION EXPERIENCE | IMMUNOHISTOCHEMISTRY | Breast Neoplasms - classification | Carcinoma - drug therapy | Receptor, ErbB-2 - genetics | Humans | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Breast Neoplasms - drug therapy | Chromosomes, Human, Pair 17 - genetics | Disease Progression | Medical Oncology | Breast Neoplasms - genetics | Antineoplastic Agents, Hormonal - therapeutic use | Carcinoma - genetics | Female | Pathology, Clinical | Neoplasm Recurrence, Local - epidemiology | Retrospective Studies | Carcinoma - classification | Molecular Probes - genetics | In Situ Hybridization, Fluorescence - methods | Practice Guidelines as Topic | Breast cancer | Diagnosis | Research | Chromosomes | Therapy | Enumeration | Copy number | Fluorescence | Population studies | Patients | ErbB-2 protein | Reclassification | Lymph nodes | Guidelines | Impact analysis | Amplification | Gene amplification | Epidermal growth factor | Converting | Fluorescence in situ hybridization | Classification | Breast | Chromosome 17 | Tumors | Cancer | Lymph
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 06/2016, Volume 140, Issue 6, pp. 529 - 535
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 04/2016, Volume 140, Issue 4, pp. 312 - 317
Journal Article
Journal Article